Physician profile
Jamell Walker
NPI 1699956680
$3,175.20
in general payments reported to CMS, 2019-2025
9 companies · $2,852 in 2025
The $2,852 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $13.80 · 2022: $69.19 · 2024: $60.40 · 2025: $2,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $1,117 · Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $1,117.09 |
| Food and Beverage | $295.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,779.32 | 2019-2025 | |
| Astellas Pharma US INC | $124.08 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $114.26 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $43.75 | 2022-2025 | Slynd |
| Allergan, INC. | $28.74 | 2019-2020 | |
| Myovant Sciences INC. | $25.11 | 2022 | |
| Davol INC. | $22.31 | 2022 | |
| Mallinckrodt Enterprises LLC | $19.90 | 2019 | |
| Sanara Medtech INC. | $17.73 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamell Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.